Plasmonix, Inc. — Form D
Plasmonix, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2012-06-07. The offering totals $500K, of which $298K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-06-07
- Form: D
- Accession: 0001521534-12-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $500K
- Amount sold: $298K
- Remaining: $202K
- Minimum investment: $464
- Investors: 15
- Date of first sale: 2012-05-24
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-179424
Issuer
- Name: Plasmonix, Inc.
- CIK: 0001521534
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2009
- Address: 9119 GAITHER ROAD, GAITHERSBURG, MD, 20877
- Phone: 410-625-5939
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Jesse E Baumgold, PhD | Director | Bethesda, MD |
| Sean M Higgins, PhD | Executive Officer | Baltimore, MD |
| James E Russo | Executive Officer | Baltimore, MD |
| John W Holaday | Director | ROCKVILLE, MD |
| John W Holaday | Executive Officer | ROCKVILLE, MD |
| Steven W Meltzer | Director | Gaithersburg, MD |
| Edward M Rudnic, PhD | Director | Gaithersburg, MD |
| Jesse Baumgold, PhD | Director | Bethesda, MD |
| Jesse Baumgold, PhD | Executive Officer | Bethesda, MD |
| David W Manyak | Director | Gaithersburg, MD |
| William M Gust, II | Director | Baltimore, MD |
| William M Gust, II | Executive Officer | Baltimore, MD |
| Jesse W Baumgold, PhD | Director | Bethesda, MD |
| Christopher D Geddes | Executive Officer | Baltimore, MD |
Other filings by this issuer (5)
More